Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001041885-26-000005
Filing Date
2026-04-23
Accepted
2026-04-23 10:01:46
Documents
1
X0202

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 5273
  Complete submission text file 0001041885-26-000005.txt   7208
Mailing Address 1 ROCKEFELLER PLAZA 7TH FLOOR NEW YORK NY 10020
Business Address 1 ROCKEFELLER PLAZA 7TH FLOOR NEW YORK NY 10020 2122697800
INGALLS & SNYDER LLC (Filed by) CIK: 0001041885 (see all company filings)

EIN.: 135156620 | State of Incorp.: NY | Fiscal Year End: 0930
Type: SCHEDULE 13G/A

Mailing Address 3204-4464 MARKHAM STREET VICTORIA BRITISH COLUMBIA British Columbia, Canada
Business Address 3204-4464 MARKHAM STREET VICTORIA BRITISH COLUMBIA British Columbia, Canada 6048060626
MindWalk Holdings Corp. (Subject) CIK: 0001715925 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0430
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-94108 | Film No.: 26886108
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)